Response to Letter on "Cognitive outcomes after fetal exposure to carbamazepine, lamotrigine, valproate or levetiracetam monotherapy: Data from the EURAP neurocognitive extension protocol"
Epilepsy Behav. 2024 Nov:160:110084.
doi: 10.1016/j.yebeh.2024.110084.
Epub 2024 Oct 15.
1 Department of Neuropsychology, HUS Neurocenter, and BABA Centre, Paediatric Research Centre, Children's Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. Electronic address: susanna.stjerna@helsinki.fi.
2 Kenter Jeugdhulp, Amstelland, Amstelveen, the Netherlands.
3 Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
4 Department of Medicine (Austin Health), The University of Melbourne (Austin Health), Melbourne, Victoria, Australia; Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
5 Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
6 Department of Neurology, Belfast Health and Social Care Trust, Belfast, United Kingdom.
7 The Epilepsy Clinic, Department of Neurology, Rigshospitalet, Copenhagen, Denmark.
8 Institute for Communicative and Cognitive Neurology, Trivandrum, India.
9 The University of Melbourne Department of Medicine Royal Melbourne Hopital and Department of Neuroscience, Central Clinical School, Monash University, Melbourne, Victoria, Australia.
10 Epilepsia Helsinki, Children's Hospital, Helsinki University Hospital, Helsinki, Finland.